INVH vs REGN · P/E 42, rev $2.62B vs P/E 14, rev $14.34B
Invitation Homes Inc (INVH) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported INVH revenue for 2024-12-31 was $2.62B. Net income was $455.4M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
INVH currently screens at market cap $19.99B and trailing P/E 41.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the INVH and REGN stock pages for the full models.
Not investment advice.